Last update June 25, 2020
Very Low Risk
We do not have alternatives for アセタゾラミド since it is relatively safe.
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
アセタゾラミド is Acetazolamide in Japanese.Is written in other languages:
アセタゾラミド is also known as
アセタゾラミド belongs to these groups or families:
Main tradenames from several countries containing アセタゾラミド in its composition:
|Tmax||2 - 3||hours|
|T½||3 - 9||hours|
|Ped.Relat.Dose||1 - 3||%|
Write us at email@example.com
e-lactancia is a resource recommended by Asociación Pro Lactancia Materna (APROLAM) of Mexico
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM
Carbonic anhydrase inhibitor diuretic that has been used in the treatment of glaucoma, intracraneal hypertension and some types of epilepsy.
Oral administration one to four times a day.
It is excreted in breast milk in clinically insignificant amounts and no problems have been observed in infants whose mothers have taken it (Ibrahim 2019, Söderman 1984). Plasma levels in these infants were very low (Söderman 1984).
Expert authors consider the use of Acetazolamide to be safe during breastfeeding (Belkin 2020, Hale 2019, Briggs 2017, Chen 2010, Schaefer 2007).
American Academy of Pediatrics: Maternal Medication Usually Compatible With Breastfeeding (AAP 2001).
List of WHO essential medicines: compatible with breastfeeding (WHO/UNICEF 2002).